Target intelligence / Profile preview

Allergenic protein from Ligustrum vulgare pollen (none as a group)

Target
none as a group
Molecular classification
Other (Allergen), Plant pollen protein, Ole e 1-like protein family, profilin, ATP synthase subunit, enolase, polygalacturonase
01

Overview

Allergenic proteins from Ligustrum vulgare (common privet) pollen are a group of plant proteins that elicit IgE-mediated allergic responses in sensitized individuals and are a recognized cause of respiratory allergies, particularly allergic rhinitis and asthma, worldwide[1][2][3][5]. The principal characterized allergen is Lig v 1, a member of the Ole e 1-like protein family, but several additional proteins (including profilin, enolase, ATP synthase subunits, and polygalacturonase) have been identified as potential allergens[2][4][6]. These proteins are found in privet pollen, which is prevalent in ornamental plantings and can provoke symptoms in sensitive people upon inhalation. Ligustrum pollen proteins are notable for cross-reactivity with other Oleaceae species such as olive, lilac, and ash, complicating both diagnosis and sensitization patterns[2][5]. While not classical therapeutic drug targets (hence "false" for is_target), they are medically important as the basis for diagnostic tests and emerging allergen-specific immunotherapies[2].

Other names
Major pollen allergen Lig v 1Ole e 1-like proteinPrivet pollen allergenCommon privet pollen allergenic proteins
02

Mechanism of action

Not applicable for classical drugs; When used as immunotherapy (allergen-specific immunotherapy): exposure induces immune tolerance, reducing allergic symptoms; Mechanism for individual allergenic proteins: triggers IgE-mediated hypersensitivity

03

Biological functions

Immune response (elicits IgE-mediated allergic reactions in humans)Other (pollen development, possibly plant fertility for some component proteins)
04

Disease associations

Inflammation (allergic rhinitis, allergic conjunctivitis, asthma)Other (allergic diseases)
05

Safety considerations

Risk of inducing or exacerbating allergic reactions (asthma, rhinitis, conjunctivitis) upon exposure to allergenCross-reactivity with allergens from olive, ash, lilac, and other Oleaceae family members, which can confuse diagnosis and management
06

Interacting drugs

None (no approved drugs directly targeting these proteins; allergen extracts or recombinant proteins are used for immunotherapy/desensitization research)
07

Biomarkers

Serum IgE specific to Lig v 1 or Ligustrum pollen proteins can indicate sensitization and are used diagnosticallySkin prick test reactivity to privet pollen extract

Beyond the preview

Go deeper on Allergenic protein from Ligustrum vulgare pollen (none as a group).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Allergenic protein from Ligustrum vulgare pollen (none as a group).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call